Company Performance Metrics
Paul McCormick: Corporate DirectorPast Role: Cardiogenesis Corporation, Chairman/Executive Chairman
Cambridge Heart, Inc. engages in the research, development, and commercialization of products for the non-invasive diagnosis of cardiac disease in the United States and internationally. The company provides Heartwave II System, which is used to perform a Microvolt T-Wave Alternans (MTWA) test; Micro-V Alternans Sensors, which are single patient
use, multi-segment electrodes that are used in MTWA tests; and CH2000 Cardiac Stress Test System, a diagnostic system to support various standard and physician-customized protocols for the conduct and measurement of cardiac exercise stress testing. It markets and sells its products primarily to cardiology group practices, physicians, hospitals, and research institutions. The company markets its products internationally through independent distributors.
